In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-20 of 20 for your search:
Drug:  O6-benzylguanine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068656, S0001, U10CA032102, SWOG-S0001, NCT00017147
2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CWRU1A96, U01CA062502, P30CA043703, NCI-T97-0021, T97-0021, NCT00004072
3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10227, UCCRC-10227, UCCRC-T99-0088, NCI-T99-0088, NCT00005066
4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 0059 (CDR0000067688), DUMC-0059-00-1, DUMC-T98-0059, NCI-T98-0059, T98-0059, NCT00005081
5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02340, UCCRC-10325, CWRU-1699, NCI-T99-0111, CDR0000067943, T99-0111, NCT00005961
6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CWRU1298, U01CA063200, P30CA043703, NCI-89, 89, NCT00005981
7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: Pro00004127 (CDR0000483768), DUMC-5515-06-1R2, DUMC-5515-04-1R0, GP-DUMC-5515-06-1R2, NCT00362921
8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000529875, NCI-07-C-0052, AOI-NCI-07-C-0052, NCT00436436
9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-03050, PBTC-015, NCI-06-C-0089, NCI-P6692, CDR0000455561, NCT00275002
10.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-7341, NCI-T94-0082C, T94-0082
11.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CWRU1994, U01CA062502, CWRU-ICC-1994, NCI-T94-0022D, T94-0022, NCT00002604
12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000065479, NABTC-9702, NCI-T96-0103, NCT00002971
13.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000066327, DUMC-1094-99-6R5, DUMC-929-97-6R3, DUMC-980-98-6R4, NCI-T94-0080, T94-0080, NCT00003348
14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-01842, POG-9870, CDR0000066891, P9870, NCT00003765
15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 9523, UCCRC-9523, NCI-T98-0038, T98-0038, NCT00003766
16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTT-9803, JHOC-NABTT-9803, NCT00004892
17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-00-C-0105I, NCI-237, 237, NCT00020150
18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068301, 1388, DUMC-1388-02-8R2, DUMC-1388-00-8, NCI-490, DUMC-1388-01-8R1, 490, NCT00006474
19.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-03174, PBTC-005, U01CA081457, CDR0000258738, NCT00052780
20.

Phase: No phase specified
Type: Treatment
Status: Completed
Age: 5 to 55
Sponsor: NCI
Protocol IDs: CCHMC-04660, 7036, NCI-7036, NCT00253487
New Search